MedTrace Logo

Pilot Randomized Controlled Trial of a Smart Phone-Based Smoking Cessation Program

NCT04955639 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2024-07-01

Study results available
· View outcomes & findings →

Summary

Two-arm, parallel-group, non-crossover, single-center pilot randomized controlled trial, enrolling up to 180 participants to evaluate the effect of the Pivot smoking cessation program (intervention) compared to usual care (commercially available app smoking cessation program plus optional nicotine replacement therapy, control).

Conditions

  • Smoking Cessation

Interventions

OTHER

Control

Standard of Care - Control Smoking Cessation Program

OTHER

Pivot

Pivot Program Smoking Cessation Program

Sponsors & Collaborators

  • Jennifer Marler, MD

    lead INDUSTRY

Principal Investigators

  • Jennifer Marler, MD · Pivot Health Technologies Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-03
Primary Completion
2022-04-27
Completion
2023-11-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955639 on ClinicalTrials.gov